Cosmos Health Launches C-ScrubVet in the UK, Advancing into the $69 Billion Global Animal Health Market
Cosmos Health has received its first orders for C-ScrubVet, a 4% chlorhexidine digluconate veterinary antimicrobial cleanser, with sales commencing in the United Kingdom and additional European markets targeted from Q4 2026. The product is certified under European standards EN 1656 and EN 1657 for bactericidal and fungicidal activity in veterinary use and is manufactured in-house at subsidiary Cana Laboratories' EU GMP-licensed, EMA-certified facility in Athens.
Key figures
- Revenue
- $65.27 million
- Guidance
- Previously issued 2029 guidance: $200.6 million revenue, $44.2 million adjusted EBITDA, $31.0 million net income
- Revenue Yoy
- 20%
- Launch market
- United Kingdom, with additional European markets from Q4 2026
- Revenue period
- FY2025
- Distribution channel
- e-commerce-led, expanding to pet store chains and veterinary clinics
- Projected market cagr
- approximately 11%
- Market projection 2026
- $75.3 billion
- Market projection 2033
- $156 billion
- Animal health market size
- $69 billion
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.